SKYCellflu Trivalent Solution for Injection in Prefilled Syringe 0.25ml

Manufacturer
SK bioscience Co., Ltd.(KOREA,SOUTH)


Registraction Number
MAL20076004AZ

Content:
•    Active Ingredient: Purified inactivated influenza virus surface antigens (A/H1N1, A/H3N2, and B/Victoria) at 7.5μg each per 0.25ml dose.
Indications:
SKYCellflu Trivalent is indicated for:
•    Prevention of influenza diseases: Caused by influenza A and B viruses for adults and children aged 6 months and older.
Instructions:
1.    Administration Schedule and Dose:
o    Children 6 months through 35 months of age who have not been previously vaccinated: Two doses of 0.25 ml, with the second dose given at least 4 weeks after the first.
o    Children 6 months through 35 months of age who have been previously vaccinated: One dose of 0.25 ml as a single injection.
o    Children 36 months through 8 years of age who have not been previously vaccinated: Two doses of 0.5 ml, with the second dose given at least 4 weeks after the first.
o    Children 36 months through 8 years of age who have been previously vaccinated: One dose of 0.5 ml as a single injection.
o    Children 9 years and older: One dose of 0.5 ml as a single injection.
2.    Mode of Administration: Inject intramuscularly into the brachial deltoid muscle using the needle attached to the prefilled syringe. For infants aged 6 months to 3 years, inject into the anterolateral thigh.
3.    Storage: Store at 2-8°C in an airtight container away from light. Do not freeze.